P53 and NFκB: Fresh breath in the cross talk

Cell Research

Volumn 19, Issue 12, 2009, Pages 1313-1315

  Tergaonkar, Vinay ^a  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P53; RAS PROTEIN;

ADENOCARCINOMA; ANIMAL; ARTICLE; CELL TRANSFORMATION; DRUG DESIGN; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; PATHOPHYSIOLOGY; REGULATORY SEQUENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

ADENOCARCINOMA; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DRUG DESIGN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; I-KAPPA B PROTEINS; LUNG NEOPLASMS; NF-KAPPA B; RAS PROTEINS; REGULATORY ELEMENTS, TRANSCRIPTIONAL; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 71749094946     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2009.132     Document Type: Article

References (16)

1. Herbst RS, Heymach JV, Lippman SM. Lung cancer. N Engl J Med 2008; 359:1367-1380.
2. Finco TS, Westwick JK, Norris JL et al. Oncogenic Ha-Ras-induced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation. J Biol Chem 1997; 272:24113-24116.
3. Hanson JL, Hawke NA, Kashatus D, Baldwin AS. The nuclear factor kappaB subunits RelA/p65 and c-Rel potentiate but are not required for Ras-induced cellular transformation. Cancer Res 2004; 64:7248-7255.
4. Tergaonkar V, Perkins ND. p53 and NF-kappaB crosstalk: IKKalpha tips the balance. Mol Cell 2007; 26:158-159.
5. Rocha S, Campbell KJ, Perkins ND. p53- and Mdm2-independent repression of NF-kappa B transactivation by the ARF tumor suppressor. Mol Cell 2003; 12:15-25.
6. Rocha S, Martin AM, Meek DW, Perkins ND. p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-kappaB subunit with histone deacetylase 1. Mol Cell Biol 2003; 23:4713-4727.
7. Meylan E, Dooley AL, Feldser DM, et al. Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma. Nature 2009; 462:104-107.
8. Folkman J, Ryeom S. Is oncogene addiction angiogenesis-dependent? Cold Spring Harb Symp Quant Biol 2005; 70:389-397.
9. Weinstein IB. Cancer: Addiction to oncogenes-the Achilles heal of cancer. Science 2002; 297:63-64.
10. Ehrenreiter K, Kern F, Velamoor V et al. Raf-1 addiction in Ras-induced skin carcinogenesis. Cancer Cell 2009; 16:149-160.
11. Chew J, Biswas S, Shreeram S et al. WIP1 phosphatase is a negative regulator of NF-kappaB signalling. Nat Cell Biol 2009; 11:659-666.
12. Greenman C, Stephens P, Smith R et al. Patterns of somatic mutation in human cancer genomes. Nature 2007; 446:153-158.
13. Bohuslav J, Chen LF, Kwon H, Mu Y, Greene WC. p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1. J Biol Chem 2004; 279:26115-26125.
14. Dey A, Wong ET, Bist P, Tergaonkar V, Lane DP. Nutlin-3 inhibits the NFkappaB pathway in a p53-dependent manner: Implications in lung cancer therapy. Cell Cycle 2007; 6:2178-2185.
15. Dey A, Wong ET, Cheok CF, Tergaonkar V, Lane DP. R-Roscovitine simultaneously targets both the p53 and NF-kappaB pathways and causes potentiation of apoptosis: Implications in cancer therapy. Cell Death Differ 2008; 15:263-273.
16. Dey A, Tergaonkar V, Lane DP. Double- edged swords as cancer therapeutics: simultaneously targeting p53 and NF-kappaB pathways. Nat Rev Drug Discov 2008; 7:1031-1040.